SMH shorts ease but options hedges remain elevated as chips slide

SMH enters the week with a notable split in how traders are positioned: short sellers have been quietly covering over the past month, yet options hedges remain well above their recent norm — an unusual divergence for a fund that rarely tells two stories at once.

The clearest tension is in price. The VanEck Semiconductor ETF has dropped 5.5% over the past week and 7.8% over the past month, closing Tuesday at $542.11. That drawdown is pulling in two directions at once — it has encouraged short covering on one side, while pushing options traders to maintain defensive positioning on the other.

Short positioning has been easing meaningfully, and that is the more surprising of the two signals. Short interest in SMH peaked at 12.4% of the free float on September 15, but that headline figure masks a steady decline from a month ago, when shares short were running roughly 12% higher than they are now. The one-month change in short interest is down 12.3%, suggesting that a meaningful cohort of bears has been reducing exposure into the selloff rather than adding to it. Borrow costs reflect that: at 0.82%, the cost to borrow is low and has eased 15% over the week, consistent with shorts returning shares rather than scrambling for new borrows. Availability has tightened modestly to 138% — still comfortably in normal territory, meaning the lending pool is far from stressed. That is not the profile of a market bracing for a squeeze; it reads more like orderly de-risking.

Options positioning tells a less comfortable story. Put demand relative to calls remains elevated, with the put/call ratio at 1.56 — still well above balanced, even though it has drifted below its 20-day average of 1.68 by roughly 1.2 standard deviations. More telling is the trajectory: the PCR has been falling steadily since mid-August, when it was running near 2.0 and at its most defensive of the past year. The drift lower suggests the hedging impulse is fading, but the ratio has not cleared 1.0 — meaning options traders remain net buyers of protection. The 52-week range for the PCR runs from 0.54 to 3.61, so the current level sits firmly in the cautious half of that band.

The ORTEX short score has been climbing quietly all week. It moved from 58.9 on September 9 to 63.0 on September 15 — a five-point gain in six sessions that places SMH in the upper tier of short-side pressure across the ORTEX universe. The score has been broadly range-bound between 62 and 64 for most of September, with a brief dip mid-week before recovering. A short score in the low 60s is not extreme, but the steady tick higher alongside a falling price is a pattern worth tracking.

Institutional flows add one more wrinkle. Goldman Sachs added 3.3 million shares in the quarter to June 30, making it the second-largest holder with a 14.4% stake. Susquehanna and Barclays also added meaningfully — 1.2 million and 870,000 shares respectively — while Morgan Stanley trimmed by 1.4 million shares and JPMorgan reduced by 527,000. Managed Account Advisors remains the largest holder at 25.9% but cut 791,000 shares in the same period. The net picture is a modest tug of war among the biggest holders, with broker-dealer positioning dominating the register in a way that reflects market-making and hedging activity as much as directional conviction.

The setup to watch: whether the short score continues to grind higher as price falls, or whether covering accelerates and pulls the score back — the gap between those two outcomes will say a great deal about whether the semiconductor sector's current weakness is drawing fresh bears or simply shaking out the ones already there.